Animal model of Gaucher's disease from targeted disruption of the mouse glucocerebrosidase gene
Animal model of Gaucher's disease from targeted disruption of the mouse glucocerebrosidase gene
复制标题
通过靶向破坏小鼠葡萄糖脑苷脂酶基因而建立的戈谢病动物模型
作者:
V. Tybulewicz;M. Tremblay;LaMarca;R. Willemsen;B. Stubblefield;S. Winfield;B. Zabłocka;E. Sidransky;B. Martin;S. Huang;K. A. Mintzer;H. Westphal;R. Mulligan;E. Ginns
GAUCHER'S disease is the most prevalent lysosomal storage disorder in humans and results from an autosomally inherited deficiency of the enzyme glucocerebrosidase (β-D-glucosyl-N-acylsphingosine glucohydrolase)1–6, which is responsible for degrading the sphingolipid glucocerebroside. An animal model for Gaucher's disease would be important for investigating its phenorypic diversity and pathogenesis and for evaluating therapeutic approaches. A naturally occurring canine model has been reported but not propagated7. Attempts to mimic the disease in animals by inhibiting glucocerebrosidase have been inadequate8. Here we generate an animal model for Gaucher's disease by creating a null allele in embryonic stem cells through gene targeting and using these genetically modified cells to establish a mouse strain carrying the mutation9,10. Mice homozygous for this mutation have <4% of normal glucocerebrosidase activity, die within twenty-four hours of birth and store glucocerebroside in lysosomes of cells of the reticuloendothelial system.